DFPG Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$374K Buy
4,482
+741
+20% +$57.7K 0.03% 468
2023
Q3
$281K Buy
3,741
+148
+4% +$11.4K 0.03% 487
2023
Q2
$284K Buy
3,593
+470
+15% +$37.5K 0.03% 481
2023
Q1
$259K Buy
3,123
+536
+21% +$44.4K 0.03% 458
2022
Q4
$226K Buy
+2,587
New +$205K 0.04% 405
2021
Q4
Sell
-16,408
Closed -$1.12M 186
2021
Q3
$1.12M Sell
16,408
-30
-0.2% -$2.11K 0.42% 67
2021
Q2
$1.12M Buy
16,438
+1,208
+8% +$80.7K 0.42% 69
2021
Q1
$1.01M Buy
15,230
+1,261
+9% +$81.3K 0.43% 68
2020
Q4
$881K Buy
+13,969
New +$843K 0.41% 72

Other funds holding GILD

DFPG Investments's GILD Position: Q4 2023 in Review

DFPG Investments increased its Gilead Sciences (GILD) stake by 20% in Q4 2023, buying an estimated $57.7K and bringing the position to 4,482 shares worth $374K. The position accounts for 0.03% of the portfolio, ranked #468.

DFPG Investments first reported a position in GILD in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.12M in Q3 2021. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • DFPG Investments held 4,482 shares of Gilead Sciences worth $374K as of Q4 2023.
  • DFPG Investments bought 741 Gilead Sciences shares in Q4 2023, an estimated $57.7K.
  • Gilead Sciences made up 0.03% of DFPG Investments's portfolio in Q4 2023, its #468 holding.
  • DFPG Investments first reported a position in Gilead Sciences in Q4 2020 and has held it in 9 quarters since.
  • DFPG Investments's Gilead Sciences position peaked at $1.12M in Q3 2021.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.